Retrospective and comparative analysis of 99mTc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women

[1]  C. Nejjari,et al.  Female Breast Cancer Incidence and Mortality in Morocco: Comparison with Other Countries , 2016, Asian Pacific journal of cancer prevention : APJCP.

[2]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[3]  Jamie E. Anderson,et al.  Comparing the National Surgical Quality Improvement Program With the Nationwide Inpatient Sample Database. , 2015, JAMA surgery.

[4]  K. Hergan,et al.  Added value of semi-quantitative breast-specific gamma imaging in the work-up of suspicious breast lesions compared to mammography, ultrasound and 3-T MRI. , 2015, The British journal of radiology.

[5]  Kyu-Tae Chang,et al.  Prognostic value of semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer , 2015, Annals of Nuclear Medicine.

[6]  Benjamin O. Anderson,et al.  Breast cancer version 2.2015: Clinical practice guidelines in oncology , 2015 .

[7]  Wanqing Chen,et al.  Female breast cancer incidence and mortality in 2011, China. , 2015, Journal of thoracic disease.

[8]  Andres Forero,et al.  Breast Cancer Version 2.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  Kenneth G A Gilhuijs,et al.  Current clinical indications for magnetic resonance imaging of the breast , 2014, Journal of surgical oncology.

[10]  Emily F Conant,et al.  Breast cancer screening using tomosynthesis in combination with digital mammography. , 2014, JAMA.

[11]  Wanqing Chen,et al.  Breast cancer in China. , 2014, The Lancet. Oncology.

[12]  N. Johnson,et al.  Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI. , 2014, American journal of surgery.

[13]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[14]  M. Tozaki,et al.  The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer , 2014, Breast Cancer.

[15]  M. Pike,et al.  Mammographic density, MRI background parenchymal enhancement and breast cancer risk. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Hui Tan,et al.  Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer , 2013, Annals of Nuclear Medicine.

[17]  Su Jung Choi,et al.  Diagnostic Performance of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer: Usefulness of Dual-Phase Imaging with 99mTc-sestamibi , 2013, Nuclear Medicine and Molecular Imaging.

[18]  Jianlun Liu,et al.  Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  Wendy B DeMartini,et al.  Background parenchymal enhancement on breast MRI: impact on diagnostic performance. , 2012, AJR. American journal of roentgenology.

[20]  B. Moon,et al.  A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts , 2012, Annals of Nuclear Medicine.

[21]  R. Brem,et al.  Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade. , 2012, The British journal of radiology.

[22]  K.P. Banks,et al.  Negative Predictive Value of Breast‐Specific Gamma Imaging in Low Suspicion Breast Lesions: A Potential Means for Reducing Benign Biopsies , 2011, The breast journal.

[23]  T. Heston,et al.  SNM Practice Guideline for Breast Scintigraphy with Breast-Specific γ-Cameras 1.0* , 2010, The Journal of Nuclear Medicine Technology.

[24]  A. Miley,et al.  Breast-Specific γ-Imaging: Molecular Imaging of the Breast Using 99mTc-Sestamibi and a Small-Field-of-View γ-Camera* , 2009, Journal of Nuclear Medicine Technology.

[25]  R. Brem,et al.  Quantification of Radio‐tracer Uptake in Axillary Lymph Nodes using Breast Specific Gamma Imaging (BSGI): Benign Radio‐tracer Extravasation versus Uptake Secondary to Breast Cancer , 2009, The breast journal.

[26]  Seema A Khan,et al.  NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[27]  P. Meunier,et al.  Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. , 2009, American journal of surgery.

[28]  N. Johnson,et al.  Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care. , 2008, American journal of surgery.

[29]  T. Canda,et al.  Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions. , 2005, Nuclear medicine and biology.

[30]  Seong-Jang Kim,et al.  Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer. , 2005, European journal of radiology.

[31]  N. Hylton,et al.  Magnetic resonance imaging of the breast prior to biopsy. , 2004, JAMA.

[32]  M. Salvatore,et al.  99mTc-MIBI in the evaluation of breast cancer biology , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  Mark A. Helvie,et al.  Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

[34]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.